PIK3CA and breast carcinoma: Sakr and colleagues conducted a comprehensive analysis involving genotyping for hotspot mutations in PIK3CA and AKT1, along with immunohistochemical assessment of PTEN, INPP4B, phosphorylated AKT and S6 expression in breast cancer progression of ductal carcinoma in situ to invasive carcinoma10.